After a Form 483 is issued and noncompliance is not corrected, what is a typical regulatory action by FDA?

• A. FDA may issue a Warning Letter or require corrective action; enforcement actions may escalate.
• B. Immediate criminal charges against facility leadership.
• C. Government seizure of all products without due process.
• D. Automatic shutdown of operations with no process.

Answer: (A)

When FDA sees uncorrected deficiencies after a Form 483, the usual path is to issue a formal Warning Letter that identifies the specific deficiencies and requires corrective actions within a defined timeframe. If those corrective actions aren’t implemented, enforcement actions can escalate to stronger measures such as recalls, seizures, injunctions, civil penalties, or even criminal action in cases of willful violations. Immediate criminal charges or automatic shutdown without due process aren’t how FDA typically proceeds; enforcement follows a process that requires due process and proportional steps.